DOJ: 7 Ohio oncologists imported misbranded drugs

CLEVELAND (AP) — Federal authorities say seven northeast Ohio oncologists have been charged with importing medications to treat cancer that the Food and Drug Administration has not approved.

The office of U.S. Attorney Steven Dettelbach in Cleveland on Tuesday said the doctors face misdemeanor charges for importing into the U.S. misbranded drugs.

Dettelbach’s office in a statement said by law, a drug may be considered misbranded even if its composition is identical to one whose label and package is FDA-approved. That rule applies even if the drug in question was produced by the same manufacturer and in the same facility as the FDA-approved version.

Authorities say the doctors could face up to one year in prison and maximum fines of $100,000 if convicted.

The doctors practice in Liverpool, Parma, Euclid, Brunswick, Westlake and Cleveland.

blog comments powered by Disqus